Serum chemerin and vaspin in non-alcoholic fatty liver disease

CHEMERIN IS AN INDEPENDENT MARKER OF THE METABOLIC SYNDROME IN A CAUCASIAN POPULATION - A PILOT STUDY

(2012) David Stejskal et al.   BIOMEDICAL PAPERS-OLOMOUC

Insulin and Metformin Regulate Circulating and Adipose Tissue Chemerin

(2009) B. K. Tan et al.   DIABETES

Cytokines in the Pathogenesis of Fatty Liver and Disease Progression to Steatohepatitis: Implications for Treatment

(2008) Christine Carter-Kent et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Vaspin: a novel serpin with insulin-sensitizing effects

(2008) Jun Wada   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes

(2008) Michiko Takahashi et al.   FEBS LETTERS

Synthetic chemerin-derived peptides suppress inflammation through ChemR23

(2008) Jenna L. Cash et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Unknown

(2008) Katja Rabe et al.   MOLECULAR MEDICINE

Serum Levels of the Adipokine Vaspin in Relation to Metabolic and Renal Parameters

(2007) Jeannette Seeger et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM